Cooler Heads secures $11M for portable scalp cooling system
The oncology-focused company will use the funds to boost manufacturing capacity, grow its commercial team and develop its next-generation Amma product.
San Diego-based Cooler Heads, a medical device company specializing in products for cancer patients, announced it closed an oversubscribed $11 million Series A funding round. Mutual Capital Partners led the round, with participation from SHD Partners, Crescent Ridge VC, Cal Innovation Fund, NuFund, Robin Hood Ventures, Golden Seeds and HIP VC.
WHAT IT DOES
Cooler Heads’ portable unit, Amma, is a self-administered scalp therapy for chemotherapy patients undergoing infusion. Amma aims to reduce blood flow to hair follicles, shielding them from chemotherapy drugs and, therefore, preventing hair loss. The device can be used to cool the scalp before, during and after chemotherapy. Due to the mobility of the unit, patients can leave their infusion chair to complete their scalp cooling therapy anywhere in the infusion center. According to the company, Amma offers a constant cooling system that eliminates the need for dry ice or repeated cap changes. The funds will be used to increase manufacturing capacity, expand the company’s commercial team and develop the next generation of Amma.
